Examples of Mundipharma in a sentence
Please learn from our experience and do not allow Mundipharma to carry on Purdue’s deadly legacy on a global stage.
On December 18, the Los Angeles Times published an extremely troubling report detailing how in spite of the scores of lawsuits against Purdue for its role in the U.S. opioid crisis, and tens of thousands of overdose deaths, Mundipharma now aggressively markets OxyContin internationally.
Today, Mundipharma is using many of the same deceptive and reckless practices to sell OxyContin abroad.
In May 2017, a dozen members of Congress sent a letter to the World Health Organization, warning it of the deceptive practices Purdue is unleashing on the rest of the world through Mundipharma: We write to warn the international community of the deceptive and dangerous practices of Mundipharma International—an arm of Purdue Pharmaceuticals.
December 2015 | News | By BioSpectrum Bureau Mundipharma announces sales and distribution collaboration of ISODINE brand Singapore: Mundipharma and Shionogi has announced a new exclusive sales collaboration contract for its ISODINE brand in Japan.
This new contract succeeds the relationship with former partner Meiji Seika Pharma.Following this agreement, Mundipharma retains the rights to the following items OTC drugs ISODINE Ugaigusuri, ISODINE Ugaigusuri P, ISODINE Ugaigusuri C, ISODINE Nodo Fresh F, ISODINE Wash, ISODINE Vulnerary and ISODINE Nankou.
Reiner is currently the Sacklers’ “Chief Business Officer” at Mundipharma.
Under the name of Mundipharma, the Sacklers are looking to new markets for their opioids— employing the exact same playbook in South America, China, and India as they did in the United States.
Additionally, we are obligated to pay Mundipharma International Corporation Limited, or Mundipharma, and Purdue Pharmaceutical Products L.P., or Purdue, a 4% royalty in the aggregate on worldwide net sales of products that were previously subject to our strategic alliance with Mundipharma and Purdue that was terminated in 2012.
It should also be borne in mind that the average consumer’s level of attention is likely to vary according to the category of goods or services in question ( Mundipharma AG v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) – Altana Pharma (RESPICUR) (T-256/04) [2007] E.C.R. II-449 at [42] and the case law cited), and I have to determine the manner in which these goods and services are likely to be selected by the average consumer in the course of trade.